61 |
111-1
|
教學研習
|
淡江大學數學系演講公告(2022-12-06 13:10:00 ~ 15:00:00)
|
62 |
111-1
|
論文指導
|
數學一碩士班 吳珮塋
|
63 |
111-1
|
論文指導
|
數學一碩士班 洪曉萍
|
64 |
111-1
|
教學研習
|
淡江大學數學系演講公告(2022-10-18 13:10:00 ~ 14:30:00)
|
65 |
111-1
|
教學研習
|
數學系演講公告(2022-09-13 13:00:00 ~ 15:00:00)
|
66 |
111-2
|
外語授課紀錄
|
國企系國商一:微積分 TLFBB1S0325 2B
|
67 |
111-1
|
教學計畫表
|
國企系國商一:微積分 TLFBB1S0325 1B
|
68 |
111-1
|
教學計畫表
|
數學系資統一:統計入門 TSMCB1S0266 0A
|
69 |
111-1
|
教學計畫表
|
數學系資統三:存活分析 TSMCB3M1043 1A
|
70 |
111-1
|
教學計畫表
|
自然科學學門:統計與生活 TNUUB0T2973 0A
|
71 |
110-2
|
教學研習
|
全英語教學經驗分享(2022-06-15 16:00:00 ~ 18:00:00)
|
72 |
111-1
|
外語授課紀錄
|
國企系國商一:微積分 TLFBB1S0325 1B
|
73 |
110-2
|
期刊論文
|
Three-Stage Pooled Plasma Hepatitis C Virus RNA Testing for the Identification of Acute HCV Infections in At-Risk Populations
|
74 |
98-2
|
期刊論文
|
Quality of life of patients with ovarian cancer in Taiwan: validation and application of the Taiwan Chinese version of the EORTC QLQ‐OV28
|
75 |
98-2
|
期刊論文
|
Quality of life of patients with oesophageal cancer in Taiwan: validation and application of the Taiwan Chinese (Mandarin) version of the EORTC QLQ-OES18: a brief communication
|
76 |
99-2
|
期刊論文
|
An inferential procedure for the probability of passing the USP dissolution test
|
77 |
100-1
|
期刊論文
|
International cross-cultural field validation of an European Organization for Research and Treatment of Cancer questionnaire module for patients with primary liver cancer, the European Organization for Research and Treatment of Cancer quality-of-life questionnaire HCC18
|
78 |
101-1
|
期刊論文
|
Statistical Methods for Bridging Studies
|
79 |
102-2
|
期刊論文
|
Sample size determination for within‐device precision
|
80 |
103-1
|
期刊論文
|
Sample size determination for individual bioequivalence inference
|
81 |
103-2
|
期刊論文
|
Quality of life changes in patients undergoing treatment for hepatocellular carcinoma
|
82 |
105-2
|
期刊論文
|
An approach for sample size determination of average bioequivalence based on interval estimation
|
83 |
104-2
|
期刊論文
|
Differences in health‐related quality of life between European and Asian patients with hepatocellular carcinoma
|
84 |
106-1
|
期刊論文
|
Prediction of plasma efavirenz concentrations among HIV-positive patients taking efavirenz-containing combination antiretroviral therapy
|
85 |
106-1
|
期刊論文
|
Use of interval estimations in design and evaluation of multiregional clinical trials with continuous outcomes
|
86 |
109-1
|
期刊論文
|
Use of a two‐sided tolerance interval in the design and evaluation of biosimilarity in clinical studies
|
87 |
108-2
|
期刊論文
|
Use of a tolerance interval approach as a statistical quality control tool for traditional Chinese medicine
|
88 |
109-1
|
期刊論文
|
Operational experiences in China and statistical issues on the conduct of clinical trials during the COVID-19 pandemic
|
89 |
109-2
|
期刊論文
|
Tolerance interval testing for assessing accuracy and precision simultaneously
|
90 |
109-2
|
期刊論文
|
Impact of efavirenz mid-dose plasma concentration on long-term weight change among virologically suppressed people living with HIV
|